Company intelligence / Profile preview

Storz Medical

Ownership: Private
Employees: ~8800
Development stage: Commercial

Overview

KARL STORZ has a long-standing global presence as a leader in endoscopic technology, offering over 13,000 products used worldwide in minimally invasive surgeries and diagnostics. The company recently expanded into digital/robotic surgery with its acquisition of Asensus Surgical. The new LUNA™ robotic platform remains under development.

Therapeutic areas: OtherOncologyGastroenterology
Modalities: DeviceDigital surgery platformImaging systemEndoscopeRobotic surgery system
Industry: Surgical Medical Devices

Partnerships

No specific major pharma partnerships noted; recent strategic expansion through M&A activity with robotics/digital health companies.

Beyond the preview

Go deeper on Storz Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Storz Medical.

Explore the full profile